CryoLife (CRY) Tops Q2 EPS by 17c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
CryoLife (CRY) PT Raised to $39 at Needham & Company
July 30, 2021 6:30 AM EDTNeedham & Company analyst Matt Matson raised the price target on CryoLife (NYSE: CRY) to $39.00 (from $38.00) while maintaining a Buy rating.
The analyst commented, "CRY's 2Q21 revenue and EPS beat consensus and management provided 2021 revenue guidance that was above consensus. Constant currency revenue... More
